Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome

Objective: Although increased central fat mass is characteristic of active Cushing’s syndrome (CS), little is known about body composition and secretion of adipokines after long-term recovery of CS. The aim of this study was to evaluate central fat mass and its correlation with adipokines and cardio...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 94; no. 9; pp. 3365 - 3371
Main Authors Barahona, María-José, Sucunza, Nuria, Resmini, Eugenia, Fernández-Real, José-Manuel, Ricart, Wifredo, Moreno-Navarrete, José-María, Puig, Teresa, Farrerons, Jordi, Webb, Susan M.
Format Journal Article
LanguageEnglish
Published Bethesda, MD Oxford University Press 01.09.2009
Copyright by The Endocrine Society
Endocrine Society
Subjects
Online AccessGet full text
ISSN0021-972X
1945-7197
1945-7197
DOI10.1210/jc.2009-0766

Cover

More Information
Summary:Objective: Although increased central fat mass is characteristic of active Cushing’s syndrome (CS), little is known about body composition and secretion of adipokines after long-term recovery of CS. The aim of this study was to evaluate central fat mass and its correlation with adipokines and cardiovascular risk factors in patients after long-term remission of CS. Methods: Thirty-seven women with CS in remission (27 of pituitary and 10 of adrenal origin; mean age, 50 ± 14 yr; mean time of hormonal cure, 11 ± 6 yr) were enrolled and compared to 14 women with active CS and 85 gender-, age-, and body mass index-matched healthy controls. Total and trunk fat mass were measured by dual-energy x-ray absorptiometry scanning. Laboratory parameters and adipokine levels [including adiponectin, visfatin, soluble TNFα-receptor 1 (sTNF-R1), sTNF-R2, and IL-6] were measured. Results: Cured CS patients had more total and trunk fat mass than controls. Cured and active CS had higher levels of sTNF-R1 and IL-6 and lower adiponectin levels than controls. Higher insulin levels and blood pressure in both groups of CS patients and higher apolipoprotein B in cured CS were observed compared to controls. sTNF-R1 correlated positively with percentage of trunk fat mass and remained significant after adjusting for anthropometric parameters. Conclusion: Despite long-term cure, patients who have suffered CS exhibit persistent accumulation of central fat, as in active hypercortisolemia, with the consequent unfavorable adipokine profile, leading to a state of low-grade inflammation. This situation determines a persistent and increased cardiovascular risk in these patients.Despite long-term cure, Cushing′s syndrome determines persistent accumulation of central fat, an unfavorable adipokine profile, low-grade inflammation, and increased cardiovascular risk, as in active hypercortisolemia.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0021-972X
1945-7197
1945-7197
DOI:10.1210/jc.2009-0766